Matches in SemOpenAlex for { <https://semopenalex.org/work/W2335113023> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2335113023 endingPage "A570" @default.
- W2335113023 startingPage "A570" @default.
- W2335113023 abstract "To evaluate psychometric properties of the revised Self-Injection Assessment Questionnaire in rheumatoid arthritis patients (pts) receiving certolizumab pegol. In the study (NCT00674362), pts with low to moderate rheumatoid arthritis (RA) received certolizumab pegol (CZP; 400mg at Weeks [Wks] 0,2, 4, then 200mg every other wk). In the open-label extension (OLE; NCT00843778), pts could self-administer CZP using a pre-filled syringe. Pts in OLE completed the revised Self-Injection Assessment Questionnaire (SIAQv2.0©) at Wks 0,2, 4,6, 8,10,12. Domain scores were calculated per authors’ recommendations, and internal consistency was assessed using the Cronbach’s alpha statistics. Floor and ceiling effects were reported as % pts with the worst/best domain score. Construct validity was assessed by confirmatory factor analysis fitting the current conceptual framework of the questionnaire and by calculating the Bentler’s Comparative Fit Index (CFI) and the root mean square error of approximation (RMSEA). 86 pts (mean age: 50.8 years; disease duration: 4.6 years) entered the OLE and completed the SIAQ at least once. At first self-injection visit, DAS28 (ESR) was 4.0 and HAQ-DI 0.9. The internal consistency of all domains was >0.8 at any visit. Floor effect was <5% at any visit; ceiling effect was ≤13% for Self-Confidence, Ease of Use (EU) and Satisfaction domains, but reached 40% for Feeling and Injection-Site Reactions domains. The ceiling effect of the EU domain was lower (10%) than the original validation (22%). The conceptual framework structure was supported by the confirmatory factor analysis with CFI values of 0.75–0.86 and RMSEA values of 0.10–0.13, which, given the limited sample size, would indicate reasonable goodness of fit. Modifications brought to the SIAQv2.0© appeared to remediate the acquiescence bias issue that was noted during the validation of SIAQv1. The appropriateness of the internal consistency reliability and construct validity of the SIAQv2.0© were confirmed." @default.
- W2335113023 created "2016-06-24" @default.
- W2335113023 creator A5014366521 @default.
- W2335113023 date "2014-11-01" @default.
- W2335113023 modified "2023-09-29" @default.
- W2335113023 title "Re-Validation of the Self-Injection Assessment Questionnaire© (Siaqv2.0©) in Rheumatoid Arthritis Patients on Certolizumab Pegol Treatment" @default.
- W2335113023 doi "https://doi.org/10.1016/j.jval.2014.08.1904" @default.
- W2335113023 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27201903" @default.
- W2335113023 hasPublicationYear "2014" @default.
- W2335113023 type Work @default.
- W2335113023 sameAs 2335113023 @default.
- W2335113023 citedByCount "1" @default.
- W2335113023 countsByYear W23351130232023 @default.
- W2335113023 crossrefType "journal-article" @default.
- W2335113023 hasAuthorship W2335113023A5014366521 @default.
- W2335113023 hasBestOaLocation W23351130231 @default.
- W2335113023 hasConcept C105795698 @default.
- W2335113023 hasConcept C106906290 @default.
- W2335113023 hasConcept C126322002 @default.
- W2335113023 hasConcept C142724271 @default.
- W2335113023 hasConcept C171606756 @default.
- W2335113023 hasConcept C1862650 @default.
- W2335113023 hasConcept C191290158 @default.
- W2335113023 hasConcept C204787440 @default.
- W2335113023 hasConcept C2776215756 @default.
- W2335113023 hasConcept C2777226972 @default.
- W2335113023 hasConcept C2777575956 @default.
- W2335113023 hasConcept C33923547 @default.
- W2335113023 hasConcept C40722632 @default.
- W2335113023 hasConcept C49453240 @default.
- W2335113023 hasConcept C70410870 @default.
- W2335113023 hasConcept C71104824 @default.
- W2335113023 hasConcept C71924100 @default.
- W2335113023 hasConceptScore W2335113023C105795698 @default.
- W2335113023 hasConceptScore W2335113023C106906290 @default.
- W2335113023 hasConceptScore W2335113023C126322002 @default.
- W2335113023 hasConceptScore W2335113023C142724271 @default.
- W2335113023 hasConceptScore W2335113023C171606756 @default.
- W2335113023 hasConceptScore W2335113023C1862650 @default.
- W2335113023 hasConceptScore W2335113023C191290158 @default.
- W2335113023 hasConceptScore W2335113023C204787440 @default.
- W2335113023 hasConceptScore W2335113023C2776215756 @default.
- W2335113023 hasConceptScore W2335113023C2777226972 @default.
- W2335113023 hasConceptScore W2335113023C2777575956 @default.
- W2335113023 hasConceptScore W2335113023C33923547 @default.
- W2335113023 hasConceptScore W2335113023C40722632 @default.
- W2335113023 hasConceptScore W2335113023C49453240 @default.
- W2335113023 hasConceptScore W2335113023C70410870 @default.
- W2335113023 hasConceptScore W2335113023C71104824 @default.
- W2335113023 hasConceptScore W2335113023C71924100 @default.
- W2335113023 hasIssue "7" @default.
- W2335113023 hasLocation W23351130231 @default.
- W2335113023 hasLocation W23351130232 @default.
- W2335113023 hasOpenAccess W2335113023 @default.
- W2335113023 hasPrimaryLocation W23351130231 @default.
- W2335113023 hasRelatedWork W1518232127 @default.
- W2335113023 hasRelatedWork W2070352318 @default.
- W2335113023 hasRelatedWork W2104435055 @default.
- W2335113023 hasRelatedWork W2114848253 @default.
- W2335113023 hasRelatedWork W2143494094 @default.
- W2335113023 hasRelatedWork W2574057140 @default.
- W2335113023 hasRelatedWork W2894078872 @default.
- W2335113023 hasRelatedWork W4221058649 @default.
- W2335113023 hasRelatedWork W4223461018 @default.
- W2335113023 hasRelatedWork W4313431671 @default.
- W2335113023 hasVolume "17" @default.
- W2335113023 isParatext "false" @default.
- W2335113023 isRetracted "false" @default.
- W2335113023 magId "2335113023" @default.
- W2335113023 workType "article" @default.